Table 5 Metabolic panel data for 22 men and women assigned to Glavonoidâ„¢ or placebo for eight weeks.
Variable | Glavonoidâ„¢ Pre (n = 11) | Glavonoidâ„¢ Post (n = 11) | Placebo Pre (n = 11) | Placebo Post (n = 11) |
|---|---|---|---|---|
Insulin (μU·mL-1) | 7.9 ± 1.3 | 9.2 ± 1.5 | 9.1 ± 0.5 | 8.4 ± 1.2 |
HOMA-IR | 1.6 ± 0.3 | 2.0 ± 0.4 | 1.9 ± 0.1 | 1.9 ± 0.3 |
Adiponectin (μg·mL-1) | 17.8 ± 1.7 | 19.0 ± 2.7 | 15.3 ± 3.4 | 15.3 ± 3.2 |
Resistin (ng·mL-1) | 5.7 ± 0.4 | 5.9 ± 0.6 | 5.1 ± 0.7 | 4.8 ± 0.5 |
Glucose (mg·dL-1) | 84.4 ± 1.9 | 85.7 ± 2.9 | 83.4 ± 2.7 | 88.0 ± 4.2 |
BUN (mg·dL-1) | 13.6 ± 1.2 | 12.6 ± 1.3 | 12.7 ± 1.0 | 13.8 ± 1.3 |
Creatinine (mg·dL-1) | 1.0 ± 0.1 | 1.0 ± 0.1 | 0.9 ± 0.0 | 0.9 ± 0.0 |
BUN:Creatinine | 14.2 ± 0.8 | 13.1 ± 0.6 | 14.3 ± 1.5 | 15.0 ± 1.6 |
Sodium (mmol·L-1)*†| 137.5 ± 0.4 | 139.0 ± 0.5 | 138.9 ± 0.5 | 139.0 ± 0.5 |
Potassium (mmol·L-1) | 4.1 ± 0.1 | 4.2 ± 0.1 | 4.3 ± 0.1 | 4.5 ± 0.2 |
Chloride (mmol·L-1) | 102.5 ± 1.1 | 102.1 ± 0.7 | 102.7 ± 0.6 | 103.1 ± 0.5 |
CO2 (mmol·L-1) | 24.0 ± 0.9 | 26.0 ± 0.8 | 24.3 ± 0.7 | 25.3 ± 0.7 |
Calcium (mg·dL-1) | 9.4 ± 0.1 | 9.2 ± 0.1 | 9.4 ± 0.2 | 9.1 ± 0.1 |
Protein (g·dL-1) | 6.9 ± 0.1 | 6.9 ± 0.1 | 6.9 ± 0.1 | 7.0 ± 0.1 |
Albumin (g·dL-1) | 4.3 ± 0.1 | 4.3 ± 0.1 | 4.3 ± 0.1 | 4.3 ± 0.1 |
Globulin (g·dL-1) | 2.6 ± 0.1 | 2.6 ± 0.1 | 2.6 ± 0.1 | 2.7 ± 0.1 |
A:G | 1.7 ± 0.1 | 1.7 ± 0.1 | 1.7 ± 0.1 | 1.7 ± 0.1 |
Bilirubin (mg·dL-1) | 0.5 ± 0.1 | 0.4 ± 0.1 | 0.6 ± 0.1 | 0.5 ± 0.1 |
Alk Phos (IU·L-1) | 67.5 ± 6.8 | 65.3 ± 6.5 | 72.6 ± 6.3 | 70.9 ± 7.4 |
AST (SGOT) (IU·L-1)** | 23.7 ± 2.5 | 26.7 ± 2.3 | 21.2 ± 2.1 | 19.9 ± 0.9 |
ALT (SGPT) (IU·L-1) | 23.5 ± 4.0 | 28.9 ± 5.2 | 20.5 ± 3.9 | 21.2 ± 4.9 |